
EU Regulators Greenlight U.S. Biotech AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO)’s Kidney Cancer Drug
European regulators have recommended the approval of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO)‘s drug for cancer treatment. The announcement is a big victory for the U.S. biotech













